Total 208, page 6/11
No. | Organization | Therapeutic Area | Product Type | Title |
---|---|---|---|---|
58 | Alborada Drug Discovery Institute | Neurology, CNS disease | Small molecule | eIF2B inhibition prevents neurodegeneration |
57 | Alborada Drug Discovery Institute | Neurology, CNS disease | Small molecule | Nuak1 inhibitor_Neurodegenerative disease |
56 | Yale University | Genetic disorders | Protein | New Modality for the treatment of ADPKD |
55 | Yale University | Metabolic disease | Nucleotide | MicroRNA-based Therapeutic for NASH |
54 | Yale University | Oncology | Nucleotide | Antisense-based Cancer Therapeutic |
53 | Yale University | Oncology | Nucleotide | A Novel piRNA-based Drug Candidate for Hepatocellular Carcinoma (HCC) |
52 | Yale University | Oncology | Small molecule | Small Molecule Inhibitors of KDM5 histone demethylases |
51 | Yale University | Oncology | Cell therapy | Universal Cancer Vaccine_Cancer |
50 | Yale University | Oncology | Gene therapy | Oncolytic virus_Brain Cancer |
50 | Stanford SPARK Program | Neurology | Small molecule | Parkinson's disease and Frontal Temporal Dementia |
49 | Ramot At Tel Aviv University | Neurology | Small molecule | Novel Specific Disease-modifying PERK Activator for Huntington's Disease |
49 | Walter and Eliza Hall | Immunology | Peptide | CD52_Autoimmune diseases |
48 | Walter and Eliza Hall | Immunology | Small molecule | RIPK2 inhibitor_IBD |
48 | Duke-NUS Medical School | Neurology | Small molecule | Treatment of Seizures Associated with Angelman Syndrome |
47 | The Scripps Research lnstitute | Neurology | Small molecule | Picrotoxinin-derived NCEs as Allosteric GABAAR antagonists |
47 | Walter and Eliza Hall | Immunology | Small molecule | Targeting plasmacytoid dendritic cells for systemic lupus erythematosus |
46 | University of Western Austrailia | Oncology | Protein | Tumour ECM-targeted Tumour Necrosis Factor (TNF) alpha |
46 | University Of Toronto | Neurology | Peptide | Peptide Therapeutics for Parkinson’s Disease |
45 | Dana-Farber | Neurology, Oncology | Small molecule | Selective Disruption of Histone Deacetylase Complexes by Protein Interaction Inhibitors to Treat Cancer and Neurological Disorders |
45 | University of Western Austrailia | Oncology | Protein | LIGHT (TNFSF14) cytokine_Cancer |